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Abstract
Blood pressure variability (BPV) is a classical physiological phenomenon. This paper describes 
major epidemiological and clinical issues of BPV which may be important to understand the 
background of this interesting feature. In healthy subjects, BPV is a measure of hemodynamic 
condition and refl ects function of autonomic nervous system. BP fl uctuations result from the 
complex interaction between environmental stimulation, genetic factors and cardiovascular 
control mechanisms. Abnormal BPV is recognized in persons with a blurred dipping pattern 
(i.e. extreme dipping, non-dipping, reverse-dipping, morning surge of BP) or increased varia-
tions of day-time or night-time BP (high BP lability). Inappropriate BPV worsens the outcome, 
including increase in all-cause and cardiac mortality and incidence of cardiovascular events, 
and advance in target organ damage. Abnormal BPV may be softened or removed with sui-
table time-dependent administration of anti-hypertensive agents, especially those acting on the 
renin–angiotensin system. (Cardiol J 2013; 20, 2: 112–120)
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Introduction 
Defi nition and assessment of BPV 
Blood pressure (BP) is changing with every 
heart beat and therefore may vary periodically 
or accidentally during day, week or in a longer 
period of time, e.g. season. As BP is labile, it 
creates a personal condition which is defi ned as 
blood pressure variability (BPV). BPV is rather 
a fl oating physiological phenomenon than a regular 
hemodynamic state. 
Short- and long-term BPV
There are several ways to express BPV. If 
BPV is measured continuously from beat-to-beat 
over an hour or up to 48 h, it is generally called 
short-term variability and assessed with Fourier 
analysis. If BP lability is re-assessed occasionally 
over longer period of time (i.e. visit-to-visit with 
offi ce or automatic BP measurement), it is called 
long-term variability. BPV may be evaluated in both 
normotensive and hypertensive subjects. 
Circadian variations in BP
In literature data, the most popular type of 
BPV is, however, dipping pattern of nocturnal 
BP. It is assessed on the basis of automatic BP 
measurement. To categorize BP it is necessary to 
calculate the night-day BP ratio from 12-h recor-
dings obtained during day and night. Four dipping 
categories have been already described: extreme 
dippers (night-day BP ratio £ 0.8 Æ BP fall at night 
> 20% compared to day-time values), dippers (ratio 
> 0.8 and £ 0.9 Æ BP fall at night ≥ 10% but less 
than 20%), non-dippers (0.9 < ratio £ 1.0 Æ no BP 
fall or BP fall at night less than 10%) and reverse 
dippers (or risers) (ratio > 1.0 Æ BP rise at night) 
(Table 1). In many researches dipping is calculated 
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as BP fall at night of at least 10% (extreme dippers 
and dippers together) and non-dipping is recogni-
zed otherwise. This method of BPV classifi cation 
is widely used in clinical studies. It is however 
debatable whether systolic (SBP), diastolic (DBP) 
or mean BP should be used to estimate the feature. 
But systolic value is the most common. 
In epidemiological and some clinical studies, 
BPV may be recognized as an individual feature 
which creates within-person variability. Then it 
describes BP variation in one person over the defi -
nite time interval. Mean or median value is a good 
estimator of BP value and standard deviation (SD) 
of the mean (or interquartile range of the median) 
are indices of BPV. When measures are taken in 
an individual subject and then collected together 
to assess mean BP of the group, between-person 
(person-to-person) variability may be evaluated. 
Every subject adds its own BP to formulate mean 
(or median) value of the cohort, and SD (or inter-
quartile range) is a measure of group BPV.
BPV is described either on the basis of ambu-
latory 24-h BP recordings or offi ce BP measure-
ments. Subjects with the SD below or above the 
mean BP of the population, measured in day-time 
or night-time are classifi ed as having low or high 
BPV. Interquartile range (or SD) of the median is 
also the acknowledged measure of variation. To 
combine mean and SD in one value, coeffi cient of 
variability (variation) can be calculated according 
to formula: CV = (SD : mean) × 100%. 
As there are few types of BP, different types of 
BPV exist in clinical setting. In experimental stu-
dies the most popular is systolic BPV; DBP is used 
less frequently. For scientifi c purposes, we can also 
distinguish pulse pressure variability (as a differen-
ce in systolic and diastolic BPV) or variability of 
mean BP (as a marker of organ tissue perfusion). 
Pulse pressure is proportional to stroke volume and 
constitutes a good marker of aortic stiffness. For 
that reason pulse pressure variability may become 
a good index of outcome in patients with advanced 
aortic arteriosclerosis or labile hypertension. 
A blunted nocturnal decrease in BP (non-dipping) is 
also independently associated with increased aortic 
stiffness in resistant hypertension [1]. 
It should be underlined that short-term and 
visit-to-visit BPV, and circadian variations of BP 
(dipping pattern) are different from physiological 
point of view and are of different clinical importan-
ce. This review will focus on circadian variations of 
BP which include assessment of the dipping pattern 
and BP changes measured in a 24-h period using 
automatic BP monitoring.
Determinants of BPV 
Non-dipping pattern may be found in up to 70% 
of subjects [2–6]. The meta-analysis of 23 studies 
including 3,476 normotensive patients has revealed 
that the average night-to-day ratio was 0.87 for SBP 
and 0.83 for DBP, with ranges across the individual 
studies from 0.79 to 0.92 for SBP and from 0.75 to 
0.9 for DBP [7]. 
BP fl uctuations result from the complex in-
teraction between environmental stimulation, 
genetic factors and cardiovascular (CV) control 
mechanisms [8]. It is diffi cult to identify determi-
nants of BPV because this is an individual trait. 
It was however found that non-dipping was more 
frequent is elder subjects [9, 10] and hyperten-
sives, especially those untreated [4, 6, 9]. In the 
study enrolling 208 treated hypertensive patients 
[4], the incidence of non-dippers were 3.3 and 2.3 
times higher in patients of ≥ 70 and those 60–69 
years of age compared to younger counterparts. 
Non-dipping pattern was statistically signifi cantly 
3.7 times more frequent amongst persons with 
a premature family history of CV disease. Moreover, 
the incidence of non-dippers was 3.0 and 4.8 times 
higher in overweight and obese patients compared 
to those with normal weight, respectively.
On the basis of measurements taken in 621 
consecutive patients undergoing ambulatory BP 
monitoring at the Cleveland Clinic, Brotman et al. 
[11] have shown that in a statistically signifi cant 
way non-dippers were older, more likely to be non-
-white and had higher rates of smoking, diabetes, 
hypertension, coronary artery disease, congestive 
failure and renal insuffi ciency. In registry data en-
Table 1. Estimation of dipping pattern on the 










Extreme dippers ≤ 0.8 ≥ 20%
Dippers (0.8; 0.9] ≥ 10% but 
< 20%
Non-dippers (0.9; 1.0] ≥ 0% but 
< 10%
Reverse dippers > 1.0 BP rise at night
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rolling 4,765 normotensive and 2,555 hypertensive 
subjects it has been revealed that after adjustment 
for potential confounders, the probability of being 
a non-dipper increased 2.8 times from 30 to 60 
years and 5.7 times from 60 to 80 years [9]. Mo-
reover, the risk of blunted nocturnal BP decline 
was 1.6-folds higher in hypertensive patients 
compared to normotensives. The problem of BPV 
is important in children and adolescents in whom 
early intervention helps to prevent complications 
of hypertension. Krzych [12] has investigated the 
issue in 204 consecutive children with essential 
hypertension. He has found that male sex increased 
the risk for non-dipping by 2.5 times (OR = 2.45; 
95% CI 0.87–6.87; p = 0.08). Gender seems to 
have no impact on BPV in adults. 
Fava et al. [13] investigated heritability of BPV 
in 118 Swedish families. Nocturnal BP dipping was 
heritable in 38% for SBP, 9% for DBP and 36% for 
mean BP. In another study [14], systolic and diastolic 
nocturnal dipping of more than 10% was heritable in 
59% for SBP and 81% for diastolic BPV. 
Reproducibility of dipping 
pattern assessment
The reproducibility of the dipping pattern has 
been a subject to many researches. The 4-week 
reproducibility of nocturnal BP fall in untreated hy-
pertensives was rather limited in the study of Cuspidi 
et al. [15]. Only 75.1% patients (including 78.7% dip-
pers, 67.6% non-dippers and 43.2% extreme dippers) 
showed no change in their diurnal variations in BP. 
They have also showed that there were no gender 
and age-related differences in the repeatability of BP 
nocturnal fall [16]. Omboni et al. [17] have revealed 
that in a 4-week period 35–40% of patients became 
non-dippers if they were dippers (or vice versa) regar-
dless of treatment. In other study [18], when the fi rst 
24-h assessment of the dipping pattern was compared 
to the estimation on the basis of 48-h recording, 11% 
hypertensive subjects switched patterns, similarly 
for SBP and DBP and with no difference between 
treated and untreated patients. In untreated patients 
with newly diagnosed hypertension, the nocturnal 
dipping pattern has been repeatable in 82% of them 
when re-assessed after 4 weeks [19]. Signifi cant 
intra-subject variations in the diurnal fl uctuations 
in BP have been found by Manning et al. [20] over 
a 12-month observation. Only 56% of normotensive 
and hypertensive patients had no change in their 
dipping status. 
There are 3 explanations for those discre-
pancies in estimation of BPV dipping pattern. 
First, BPV is a physiological phenomenon and by 
defi nition may vary over time. Second, the most 
appropriate method for defi ning day and night in 
published papers is not consistent. Henskens et 
al. [21] have proven that use of different defi ni-
tions of awake-sleep and BP indices affected the 
classifi cation of nocturnal BP dipping signifi cantly, 
with the repeatability coeffi cients of no more than 
48.7% and kappa values between 0.323 and 0.459. 
However in the study of Verdecchia et al. [22], the 
area under the ROC curve of the night-to-time 
ratio of SBP in the assessment of CV events was 
comparable when using different clock-dependent 
or independent defi nitions of day and night. Ad-
ditionally, the method of BP measurement is of 
some importance. Staessen et al. [9] has found 
that the risk of being a non-dipper was 2.4 times 
higher for subjects examined with auscultatory vs. 
oscillometric devices. Third, the impact of treat-
ment, including pharmacotherapy on BPV is also 
an important point of interest. 
Impact of pharmacotherapy on BPV 
The potential benefi t of bedtime chronothera-
py with at least one hypotensive agent was investi-
gated in the MAPEC study [23]. It has been found 
that despite lack of differences in ambulatory BP 
between groups of subjects who were randomized 
either to awakening or bedtime administration of 
medications, patients from the latter group showed 
higher sleep-time BP decline and reduced preva-
lence of non-dipping (34% vs. 62%). In this study, 
subjects taking more than 1 medication at bedtime 
showed signifi cantly lower mean sleep-time BP 
than those ingesting all their medications upon 
awakening. Those differences were slightly greater 
for SBP (~ 4.4 mm Hg) than DBP (~ 4.3 mm Hg). 
The asleep and awake BP were lower for those who 
were administrated medications at bedtime [23]. 
Also in the study of Takeda et al. [24] bedtime 
administration of long-acting antihypertensive 
drugs helped to restore a proper dipping pattern in 
71% of non-dippers. On contrary, only incomplete 
benefi t of antihypertensive therapy on stroke re-
duction in older hypertensives has been documen-
ted [25]. The stroke rates were similar according 
to medication vs. no-medication in extreme dippers 
(12% vs. 13%) and reverse dippers (23% vs. 22%), 
but in non-dippers there was a signifi cantly lower 
rate in the medicated vs. non-medicated (4.4% vs. 
13%) groups. Also in dippers, the stroke rate was 
lower in the medicated compared to non-medicated 
(4.7% vs. 8.8%) patients. Kario and Shimada [26] 
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have revealed that after treatment with calcium 
channel blocker (CCB), amlodypine, the daytime 
BP was reduced in dippers, extreme dippers and 
non-dippers. The night-time BP was signifi cantly 
lower only in dippers and non-dippers but not in 
extreme dippers. Additionally, positive correlations 
were found between baseline BP levels and BP 
reductions after treatment. In the study enrolling 
hypertensive subjects [4], compared with patients 
treated with long-acting CCB, patients treated with 
angiotensin-converting enzyme inhibitors (ACE) or 
angiotesin II receptor blockers (ARB) alone were 
less frequently non-dippers (OR = 0.139; p = 0.01). 
Subjects treated with joint CCB + ACE or CCB 
+ ARB therapy had tendency of lower incidence 
of non-dipping (OR = 0.453; p = 0.1). Moreover, 
those treated with joint therapy including diuretics 
+ CCB and diuretics + ACE or ARB were also of 
less frequency of non-dipping pattern: OR = 0.378; 
p = 0.03 and OR = 0.273; p = 0.01, respectively 
[4]. On the other hand, similar comparison of the 
effects of ACE inhibitor and CCB in hypertensives 
[27] has proven that CCB could be more effective, 
especially in the night-time BP reduction in non-
-dippers. In a prospective, randomized trial with 
ACE inhibitor, captopril, it was shown that at the 
end of the active treatment period, the prevalence 
of a dipping pattern in the captopril group was more 
than 7 times higher than in the placebo group [28]. 
Additionally, the night-to-day ratio and night-time 
BP load were signifi cantly lower after 4 weeks of 
treatment with captopril administrated at bedtime. 
Mathematic indices, such as trough-to-peak 
ratio and the smoothness index, represent useful 
measures of the homogeneity of the antihyperten-
sive effect over 24 h. 
Mechanism driving BPV 
Neuroendocrine mechanism are major deter-
minants of BP variations responsible also for BP 
dipping pattern. At the central nervous system, 
integration of the major driving factors of this tem-
poral variability is mediated by circadian rhythms 
of monoaminergic systems in conjunction with 
peripheral level, including the hypothalamic–pi-
tuitary–adrenal, hypothalamic–pituitary–thyroid, 
opioid, renin–angiotensin–aldosterone, endothelial 
systems and vasoactive peptides [29]. Those hu-
moral secretions are typically episodic, coupled to 
the circadian endogenous central pacemaker clock, 
but have some seasonal variations. Sleep induction 
and arousal are infl uenced also by many hormones 
and chemical substances that exhibit 24-h variation 
(e.g. arginine vasopressin, vasoactive intestinal 
peptide, melatonin, somatotropin, insulin, steroids, 
serotonin, corticotropin-releasing factor, adre-
nocorticotropic hormone, thyrotropin-releasing 
hormone, endogenous opioids, and prostaglandin 
E2), all with established responsiveness in the CV 
system. As a consequence, physical, mental, and 
pathologic stimuli that activate or inhibit neuro-
endocrine effectors of biological rhythmicity may 
also interfere with, or modify, the temporal BP 
structure. Moreover, immediate adjustment to 
exogenous components/environment demands by 
BP rhythms is modulated by the circadian-time-
-dependent alertness of biological oscillators and 
their neuroendocrine effectors [29].
Alteration in autonomic function plays the 
pivotal role in creating BPV [30] and non-dippers 
are characterized with an abnormal pattern of au-
tonomic activity with higher sympathetic and lower 
parasympathetic modulation [31–32]. The reverse 
dipping state has been recognized to be related 
with a sympathetic activation greater for magni-
tude that seen in the other conditions displaying 
abnormalities in night-time BP pattern [33]. It 
has been also found that autonomic neuropathy is 
the pivotal factor of blunted nocturnal fall in BP 
in both type 1 and 2 diabetic patients [34], also in 
non-insulin-dependent diabetic subjects [35]. The 
study investigating autonomic nervous system 
activity in essential hypertension has documented 
that impaired CV refl exes might contribute to the 
decreased sympathovagal balance in non-dippers 
[36]. Additionally, Kario et al. [37] concluded that 
diurnal BP variation in elderly hypertensive pa-
tients could be associated with factors regulating 
circulating blood volume and impaired sensitivity of 
adrenergic reactivity. Night-time alpha-adrenergic 
blockade with doxazosine may markedly affect the 
nocturnal BP dipping status of hypertensives with 
grater reduction observed in non-dippers and risers 
than dippers [38]. 
Additional evidence is given by studies inve-
stigating the impact of physical activity on BPV. 
Physical activity is one of the determinants of 
ambulatory BP and its diurnal variations [39]. This 
effect has been investigated by Cavelaars et al. [40]. 
They have documented that non-dippers differed 
from dippers by an increase of vascular resistance 
during the night, and the degree of physical activity 
normally encountered during ambulatory monito-
ring had little infl uence on the diurnal BP profi le 
or dipping status. The impact of time of day for 
exercise on BP dipping pattern in hypertensives 
has been investigated by Park et al. [41]. In this 
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study, non-dippers responded to exercise irrespec-
tively of time of day and non-dippers responded to 
exercise differently than dippers. Evening exercise 
exhibited a greater reduction in SBP at night in 
non-dippers than dippers and morning exercise had 
similar effect on day-time and 24 h SBP reduction 
both in dippers and non-dippers. Furthermore, the 
duration of the BP reduction persisted up to 24 h 
after exercise [41]. 
The influence of day-time activity of BPV 
merits further description due to ambiguous exis-
ting researches’ fi ndings. Investigating impact of 
aerobic exercise on the circadian BPV, no effects 
were observed either for SBP or DBP in young 
healthy subjects [42]. In 39 untreated hyper-
tensives, Mansoor et al. [43] found poor overall 
correlation between BP and activity level with 
marked between-subject variability in the strength 
of association. Moreover, almost similar results 
were revealed for dippers and non-dippers. On 
the contrary, Izdebska et al. [44] have shown that 
after a non-standardized 3-month moderate aerobic 
training, mildly hypertensive young adults had 
a statistically signifi cant decrease in SBP variations 
compared to healthy normotensive counterparts. 
Those fi ndings are in agreement with Narkiewicz 
et al. [45] who confi rmed that there is a signifi cant 
positive interaction between sympathetic traffi c 
and day-time BPV, and in normotensive males gre-
ater BP decline at night was related to the greater 
activity during day-time. 
Taking altogether, it is however clear that 
baseline BP condition should be taken into account 
in data interpretation.
The issue of inflammation and metabolic 
imbalance are also of great importance in the 
pathogenesis of abnormal BP variations. Essential 
hypertensive non-dippers compared to dippers 
have been found to exhibit higher high-sensitive 
C-reactive protein values [46]. Furthermore, am-
bulatory and nocturnal systolic BP fall interrelated 
and participated in the infl ammatory process that 
accompanied non-dipping pattern. Reactive oxy-
gen species formation was signifi cantly increased 
in extreme dippers [47]. In non-dippers however 
interruption in hemostastic condition has also 
been noticed [48], with the increase in D-dimer, 
plasminogen activator inhibitor-1 and intercellular 
adhesion molecule-1 concentrations. 
Subjects with metabolic syndrome have an 
increased prevalence of abnormal dipping pattern 
as the number of metabolic syndrome components 
rise [49]. Patients with metabolic syndrome are 
more frequent non-dippers (38.9% vs. 24.5%) and 
reverse dippers (6.3% vs. 3.3%) and less frequen-
tly dippers (43.5% vs. 54.4%) or extreme dippers 
(11.3% vs. 17.8%) compared to patients without 
this metabolic imbalance [50]. Non-dipping pattern 
has been found to correlate with glucose intole-
rance [51]. Hyperglycemia may also be associated 
with abnormal diurnal BP variation [52] but inte-
restingly, insulin resistance failed to be connected 
with nocturnal BP dipping in obese hypertensives 
[53] (Table 2). 
Clinical consequences 
of abnormal BP variations 
Blood pressure variations may contribute to 
prognosis. The dipping pattern and the night-day 
BP ratio signifi cantly predicted mortality and CV 
events in hypertensive patients with [54] and 
without [55, 56] history of major CV disease, even 
after adjustment for BP values. Fagard et al. [54] 
have found in the former group that the outcome 
was worse in reverse dippers and non-dippers com-
pared to dippers, and in the latter population [55, 
56] the incidence of CV events was higher only in 
reverse dippers, whereas mortality was lower in 
extreme dippers. Additionally, the systolic night-
-day BP ratio independently predicted all-cause 
mortality and CV events. Those findings were 
Table 2. Mechanisms with significant impact on altered blood pressure variations.
Mechanism Explanation 
Autonomic nervous system 
dysfunction 
Impaired vascular reflexes
Improper adrenergic stimulation 
Inflammation −C-reactive protein concentration 
Endothelial dysfunction Hemostatic imbalance (−D-dimer, −plasminogen activator inhibitor-1, 
−intercellular adhesion molecule-1)
Metabolic imbalance Strict relationship with the number of metabolic syndrome components
Hyperglycemia favors blood pressure variations
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confi rmed regardless of gender, age and history of 
treatment of hypertension. Over a 10-year follow-
-up of persons with or without hypertension, Li et 
al. [57] have confi rmed that the night-day BP ratio 
was a strong predictor of all-cause mortality but no 
association was found for CV events. Also in the 
multi-center study of Boggia et al. [58], the night-day 
ratio predicted mortality but not fatal combined with 
non-fatal events in a cohort of 7,458 subjects. In the 
Syst-Eur Trial of over 800 elder patients randomized 
to active treatment of hypertension (nitrendipine 
+ enalapril and/or hydrochlorothiazide) or to placebo 
[9], CV risk increased with a higher night-day BP 
ratio of SBP (HR = 1.41 per 10% increase) only 
in a placebo group. In the same cohort of patients, 
the risk of stroke increase by 80% for every 5 mm Hg 
increase in night-time systolic BPV [59]. The night-
-day BP ratio is also a useful indicator providing 
signifi cant prognostic information in patients with 
end-stage renal disease [60] and extreme dippers 
with chronic kidney disease had a 2.6-fold higher 
risk of CV events [61]. Rahman et al. [62] have 
shown that hemodialysis patients were usually 
non-dippers and the degree of decline in nocturnal 
BP was independently associated with left ventricle 
hypertrophy. 
A detailed insight into the impact of circadian 
BP fl uctuations on prognosis was the main goal 
of the MAPEC study. Hermida et al. [23, 63] pro-
spectively studied 3,344 patients who were rando-
mized into group of subject ingesting at least one 
hypotensive agent at bedtime or not. In the whole 
study population only asleep SBP was a signifi cant 
predictor of outcome (any CV events, including CV 
morbidity and mortality). Even after adjustment 
for potential confounders, the CV risk decreased 
by 17% for every 5 mm Hg decrease in asleep SBP. 
The reduced risk was confi rmed for both subjects 
with either normal (HR = 0.81) or elevated BP 
(HR = 0.84). For those with high BP, reduction 
in the risk was different if all medications were 
given on awaking (HR = 0.76) or at bedtime (HR 
= 0.67). After a 5.6-follow-up subjects ingesting at 
least one BP-lowering agent at bedtime exhibited 
a signifi cantly lower risk of all CV events (RR = 0.39) 
and major events (RR = 0.33) than those taking 
all drugs upon awaking. Noteworthy, non-dippers 
more frequent amongst CV event-subjects than 
dippers (73% vs. 46%, p < 0.001). 
A blunted reduction in nocturnal BP and high 
variations in diurnal BP may play a pivotal role in 
the development of target organ damage in essen-
tial hypertensive patients, including left ventricle 
hypertrophy and intima media thickening [64–66]. 
Regardless of BP values, never-treated hypertensive 
non-dippers have shown a signifi cantly greater extent 
of target organ damage compared to dippers [67]. The 
measures of target organ damage were left ventricu-
lar mass index, interventricular septum thickness, 
left atrium and aortic root diameters. Those fi ndings 
have been confi rmed recently by Ivanovic et al. [68]. 
Patients with abnormal diurnal BP variation patterns 
(non-dippers, extreme dippers and reverse dippers) 
have also showed higher plasma BNP levels than 
those with normal BPV [69] and reverse dippers had 
higher microalbumin and micoglobulin excretion, and 
albumin/creatinine ratio [70]. 
Blunted reduction of systolic and diastolic 
night-time BP has been found to be associated 
with poorer cognitive performances estimated on 
the basis of the Mini Mental State Examination 
[71]. Moreover Guo et al. [72] has documented 
that mild cognitive impairment was more frequent 
in extreme dippers (32%), non-dippers (30%) and 
risers (50%) than in dippers (13.2%). 
Furthermore, in resistant hypertension, the 
non-dipping pattern has been shown to be an 
independent predictor of CV mortality and the 
composite end point of fatal or non-fatal CV events, 
all-cause mortality and CV mortality [73, 74]. Non-
-dippers and reverse dippers were also at increased 
risk of CV events [73–75]. Also, non-dipping and 
reverse dipping were relatively common patterns 
of circadian BPV seen in acute stroke patients [76]. 
Additional data is given by Bastos et al. [77] who 
have revealed that compared to treated hyperten-
sive subjects with no history of cerebral events, 
those with previous stroke or transient ischemic 
attack were more frequently extreme dippers 
(10.6% vs. 6.3%), non-dippers (48.9% vs. 41.7%) 
and reverse dippers (12.8% vs. 7.6%). Moreover, 
patients with hypertension who suffered from any 
coronary event in the past were also more frequ-
ently non-dippers (56.3% vs. 43%) and reverse 
dippers (18.8% vs. 5.9%) [77]. CV events were 
more frequent also in hypertensive non-dippers 
aged 65 years or less [10] and in reverse dippers 
with or without diabetes type 2 [78]. In a 9-year 
follow-up study [79], type 2 diabetic patients with 
non-dipping pattern were at higher risk of death as 
compared to dippers. Non-dippers with diabetes are 
at increased risk of death, regardless of diabetes 
type [80], and the combination of non-dipping and 
subsequent renal impairment leads to the highest 
mortality rate. Reverse-dipping status in hyperten-
sive diabetics almost 3 times (HR = 2.79) increased 
the risk of CV events but the effect disappeared 
after adjustment for 24-h BP. Abnormal BP dipping 
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status has been documented to increase risk of de-
ath or hospitalization for heart failure exacerbation 
[81] and non-dipping pattern has been associated 
with an over 2-times higher risk of congestive 
heart failure in initially healthy Finish male [82]. 
Finally, non-dippers with sustained hypertension 
have been found to be at a 2-fold higher risk of 
developing atrial fi brillation than dippers [83]. 
On the other hand, no association between 
nocturnal decline in BP and mortality has been 
found in the Ohasama cohort study [84]. Although 
both nocturnal hypotension and erratic diastolic 
BPV assessed by Fourier spectral analysis predic-
ted mortality, subsequent study of the PAMELA 
data has failed to prove any relationship between 
the risk of death and 24-h, day-time and night-time 
BPV expressed as SDs [85]. Also in the study of 
Hansen et al. [86, 87] recruiting subjects from 
11 populations, there was no prognostic value of 
reading-to-reading BPV and in the study of Gavish 
et al. [88] there was no ability of the BPV to pre-
dict the outcome on the basis of the ratio of 24-h 
ambulatory systolic BPV to diastolic variability. 
Finally, recent fi ndings designate that the mean 
nocturnal BP value is the most sensitive predictor 
of cardio- and cerebrovascular morbidity, and mor-
tality [89–90]. Moreover, regardless of the relative 
circadian BP values, insuffi cient BP fall at night 
compared to day-time level or a high night to day 
BP ratio is associated with poor prognosis [89, 90]. 
Conclusions
Blood pressure variability is a classical phy-
siological phenomenon as BP varies individually 
continuously and episodically. In healthy subjects, 
BPV is a measure of hemodynamic condition and 
refl ects function of autonomic nervous system. BP 
fl uctuations result from the complex interaction 
between environmental stimulation, genetic factors 
and CV control mechanisms. Abnormal BPV is re-
cognized in persons with a blurred dipping pattern 
(i.e. extreme dipping, non-dipping, reverse-dipping, 
morning surge of BP) or increased variations of day-
-time or nigh-time BP (high BP lability). Inappro-
priate BP decline at night worsens the outcome, 
including increase in all-cause and cardiac mortality 
and incidence of CV events, and advance in target 
organ damage. Abnormal BPV may be softened or 
removed with suitable time-dependent administra-
tion of anti-hypertensive agents, especially those 
acting on the renin–angiotensin system. 
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